OA22.02 Dynamics of mucosal immune responses elicited by systemic prime/boost vaccinationOral Abstract SessionNovel vaccine and other prevention approaches
PE21.01 gp120-mediated CD4+ T cell activation is inhibited by non-neutralizing V2 loop antibodiesE-posterNovel vaccine and other prevention approaches
PE21.02 CD40-targeted vaccine increases magnitude of HIV-Env specific responsesE-posterNovel vaccine and other prevention approaches
PE21.04LB Advances in the use of a bacterially derived glycoside for inducing oligomannose-targeted neutralizing antibodies to HIV-1E-posterNovel vaccine and other prevention approaches
PE21.05LB Immunization with HIV-1 fusion peptide carrier conjugate in a cocktail with HIV-envelope trimer elicits potent and cross-clade neutralization activity in guinea pigsE-posterNovel vaccine and other prevention approaches
PE21.07LB HIV-1 fusion peptide (FP) conjugate and envelope trimer cocktail immunization elicit diverse FP-directed neutralizing antibodies in non-human primatesE-posterNovel vaccine and other prevention approaches
PE22.01 Directly Observed Therapy (DOT) can be Implemented Successfully in Research Settings to Evaluate PrEP PK among Pregnant and Postpartum Adolescents and Young Women in AfricaE-posterNovel vaccine and other prevention approaches
PU21.01 Willingness of adolescent girls and young women in Kampala, Uganda to participate in future efficacyttrials of novel biomedical HIV prevention interventions: the anti-retroviral implantPublication OnlyNovel vaccine and other prevention approaches
PU21.02 Comparison of HIV incidence in simulated vaccine efficacy trials and observational cohorts using propensity scores in key populations in UgandaPublication OnlyNovel vaccine and other prevention approaches
PU21.03 Co-display of hyperstabilized HIV-1 envelope glycoprotein trimers on two-component protein nanoparticlesPublication OnlyNovel vaccine and other prevention approaches
seek-warrow-warrow-eseek-e81 - 90 of 444 items